Y Fong

Author PubWeight™ 201.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1988 13.42
2 Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999 7.04
3 Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001 5.94
4 Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg Gynecol Obstet 1987 4.18
5 Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med 1988 4.02
6 Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1988 3.30
7 Segment-oriented hepatic resection in the management of malignant neoplasms of the liver. J Am Coll Surg 1998 3.04
8 Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 1998 2.97
9 Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998 2.81
10 Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 2000 2.60
11 Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 2001 2.57
12 Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 1999 2.57
13 Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 2000 2.48
14 Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg 1996 2.39
15 Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol 2008 2.12
16 One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique. Arch Surg 1994 2.03
17 Management of 155 patients with benign liver tumours. Br J Surg 2001 1.97
18 Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 2000 1.85
19 Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models. FASEB J 1989 1.82
20 Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol 1999 1.75
21 Results of hepatic resection for sarcoma metastatic to liver. Ann Surg 2001 1.75
22 Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 1993 1.73
23 Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg 2001 1.69
24 Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery 1997 1.68
25 Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207). FASEB J 1999 1.64
26 Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol 2003 1.63
27 Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription. J Biol Chem 2000 1.59
28 A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 2001 1.57
29 A prospective analysis of staging laparoscopy in patients with primary and secondary hepatobiliary malignancies. J Gastrointest Surg 2000 1.57
30 Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet 1990 1.50
31 Surgical options in the treatment of hepatic metastasis from colorectal cancer. Curr Probl Surg 1995 1.40
32 Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol 2009 1.39
33 The Caenorhabditis elegans maternal-effect sterile proteins, MES-2, MES-3, and MES-6, are associated in a complex in embryos. Proc Natl Acad Sci U S A 2001 1.32
34 Cholangiocarcinoma at the hepatic hilus: sonographic findings. AJR Am J Roentgenol 1997 1.32
35 Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery 1998 1.32
36 Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LPS) administration to normal human subjects. Influence of elicited hormones and cytokines. Ann Surg 1989 1.27
37 Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer. Cancer Gene Ther 2006 1.23
38 Prevention of hepatic tumor metastases in rats with herpes viral vaccines and gamma-interferon. J Clin Invest 1997 1.22
39 What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease? J Am Coll Surg 2001 1.21
40 Complete resection of the caudate lobe of the liver: technique and results. Br J Surg 1996 1.21
41 Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg 2007 1.19
42 Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. J Am Coll Surg 1999 1.18
43 Isolated hepatic splenosis: first reported case. HPB Surg 1998 1.18
44 Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J 1989 1.17
45 Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the species-specific Tat activation of HIV-1 transcription. Proc Natl Acad Sci U S A 1999 1.15
46 Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology 1996 1.14
47 Natural ceramide reverses Fas resistance of acid sphingomyelinase(-/-) hepatocytes. J Biol Chem 2000 1.14
48 Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol 2012 1.14
49 A technique for the use of cryosurgery to assist hepatic resection. J Am Coll Surg 1995 1.13
50 Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus. J Virol 2001 1.12
51 The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol 2003 1.12
52 Recent advances in hepatic resection. Semin Surg Oncol 2000 1.11
53 Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer. Neoplasia 2001 1.11
54 Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma. Hum Gene Ther 2001 1.10
55 Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography. AJR Am J Roentgenol 1998 1.09
56 Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg 1995 1.09
57 Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer. Nat Med 2001 1.08
58 Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence. Am J Surg 1998 1.07
59 Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg 1997 1.07
60 Role of chest CT in patients with negative chest x-rays referred for hepatic colorectal metastases. Ann Surg Oncol 1998 1.06
61 Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus. J Am Coll Surg 2001 1.06
62 Genetically engineered Newcastle disease virus for malignant melanoma therapy. Gene Ther 2009 1.04
63 Effects of preexisting immunity on the response to herpes simplex-based oncolytic viral therapy. Hum Gene Ther 2000 1.04
64 Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumour of the pancreas. Br J Surg 2007 1.03
65 Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer. J Mol Med (Berl) 2000 1.03
66 Radiofrequency ablation in the management of liver metastases from breast cancer. AJR Am J Roentgenol 2007 1.02
67 Tolerance to endotoxin prevents mortality in infected thermal injury: association with attenuated cytokine responses. J Infect Dis 1992 1.02
68 Hepatic resection for metastatic gynecologic carcinomas. Gynecol Oncol 1997 1.02
69 Hepatic lobar atrophy: association with ipsilateral portal vein obstruction. AJR Am J Roentgenol 1996 1.01
70 Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases. Ann Surg Oncol 2013 1.01
71 Cachectin/TNF production in experimental burns and Pseudomonas infection. Arch Surg 1988 1.01
72 Use of preoperative autologous blood donation in liver resections for colorectal metastases. Am J Surg 1998 1.01
73 Intravesical oncolytic viral therapy using attenuated, replication-competent herpes simplex viruses G207 and Nv1020 is effective in the treatment of bladder cancer in an orthotopic syngeneic model. FASEB J 2001 1.01
74 Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses. J Gastrointest Surg 2001 1.00
75 Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207). Hum Gene Ther 1999 1.00
76 Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 2001 0.99
77 Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer 1999 0.99
78 Role for surgical cytoreduction in multimodality treatments for cancer. Ann Surg Oncol 2001 0.99
79 Long-term outcomes following microwave ablation for liver malignancies. Br J Surg 2014 0.99
80 Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Ann Oncol 2009 0.98
81 Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases. Eur J Surg Oncol 2001 0.98
82 Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase. Cancer Res 2000 0.98
83 Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer. Ann Surg 2001 0.97
84 Tumor involvement in hepatic veins: comparison of MR imaging and US for preoperative assessment. Radiology 1998 0.97
85 Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res 1996 0.97
86 Characterization of a new EBV-associated nasopharyngeal carcinoma cell line. Cancer Genet Cytogenet 1998 0.96
87 Two distinct regions of deletion on chromosome 13q in primary nasopharyngeal carcinoma. Int J Cancer 1999 0.95
88 Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. Ann Surg Oncol 2011 0.95
89 Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: a double-blind, randomized controlled study. J Clin Endocrinol Metab 1992 0.95
90 Complex postcholecystectomy biliary disorders: preliminary experience with evaluation by means of breath-hold MR cholangiography. Radiology 1998 0.94
91 Recognition of intrabiliary hepatic metastases from colorectal adenocarcinoma. HPB Surg 2000 0.94
92 Cytokine-secreting herpes viral mutants effectively treat tumor in a murine metastatic colorectal liver model by oncolytic and T-cell-dependent mechanisms. Cancer Gene Ther 2007 0.94
93 Use of phosphorous-31 nuclear magnetic resonance spectroscopy to determine safe timing of chemotherapy after hepatic resection. Cancer Res 2000 0.94
94 Long range-inverse PCR (LR-IPCR): extending the useful range of inverse PCR. Genet Anal 1996 0.93
95 Particle embolization for hepatocellular carcinoma. J Vasc Interv Radiol 1998 0.92
96 Hepatocellular carcinoma: MR imaging findings in cirrhotic livers and noncirrhotic livers. Radiology 1999 0.91
97 Hepatocellular membrane function during chronic burn injury. J Surg Res 1989 0.90
98 Fluorescent cholangiography in a mouse model: an innovative method for improved laparoscopic identification of the biliary anatomy. Surg Endosc 2006 0.89
99 Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy. Cancer Gene Ther 2006 0.89
100 A novel approach to cancer therapy using an oncolytic herpes virus to package amplicons containing cytokine genes. Mol Ther 2001 0.89
101 Staging laparoscopy for potentially resectable noncolorectal, nonneuroendocrine liver metastases. Ann Surg Oncol 2002 0.89
102 Initial experience with hand-assisted laparoscopic distal pancreatectomy. Surg Endosc 2005 0.89
103 Gallbladder cancer: can ultrasonography evaluate extent of disease? J Ultrasound Med 1998 0.89
104 Extended left hepatectomy. World J Surg 1999 0.89
105 Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: implications for autologous vaccine production. Hum Gene Ther 1996 0.88
106 Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer. Mol Med 2001 0.88
107 Differential neutrophil activation before and after endotoxin infusion in enterally versus parenterally fed volunteers. Surg Gynecol Obstet 1988 0.88
108 Surgical treatment of malignant liver tumours. Baillieres Best Pract Res Clin Gastroenterol 1999 0.87
109 Interferon gamma protects against hepatic tumor growth in rats by increasing Kupffer cell tumoricidal activity. Hepatology 1996 0.87
110 Metastatic liver tumors. Semin Surg Oncol 2000 0.87
111 Identification of a novel tumor necrosis factor alpha/cachectin from the livers of burned and infected rats. Arch Surg 1990 0.87
112 Hepatic arterial nodal metastases in pancreatic cancer: is this the node of importance? J Gastrointest Surg 2013 0.86
113 Comparison of magnetic resonance and endoscopic retrograde cholangiopancreatography in malignant pancreaticobiliary obstruction. Arch Surg 1999 0.86
114 The effectiveness of a topical antibiotic irrigating solution in a model of staphylococcal keratitis after lamellar keratectomy. Am J Ophthalmol 2000 0.86
115 Synergistic action of oncolytic herpes simplex virus and radiotherapy in pancreatic cancer cell lines. Br J Surg 2010 0.86
116 Analysis of the sex chromosome constitution of sperm in men with a 47, XYY mosaic karyotype by fluorescence in situ hybridization. Fertil Steril 1999 0.86
117 Surgical resection of metastatic liver tumors. Surg Oncol Clin N Am 1996 0.86
118 Clinical factors associated with positive bile cultures during primary percutaneous biliary drainage. J Vasc Interv Radiol 1998 0.85
119 Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg 1998 0.85
120 Hepatocellular carcinoma: current surgical management. Semin Oncol 2001 0.85
121 Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer. Cancer Gene Ther 2000 0.85
122 A Drosophila gene promoter is subject to glucose repression in yeast cells. Proc Natl Acad Sci U S A 1994 0.84
123 Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity. Mol Med 1999 0.83
124 Obstructive jaundice in patients receiving hepatic artery infusional chemotherapy: etiology, treatment implications, and complications after transhepatic biliary drainage. J Vasc Interv Radiol 1997 0.83
125 Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model. Ann Surg 2000 0.83
126 Estimates of sperm sex chromosome disomy and diploidy rates in a 47,XXY/46,XY mosaic Klinefelter patient. Hum Genet 1999 0.83
127 Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection. Cancer Gene Ther 2003 0.82
128 ONCOLYTIC HERPES SIMPLEX VIRUS 1 (HSV-1) VECTORS: INCREASING TREATMENT EFFICACY AND RANGE THROUGH STRATEGIC VIRUS DESIGN. Drugs Future 2010 0.82
129 Recurrent gallbladder carcinoma along laparoscopic cholecystectomy port tracks: CT demonstration. Radiology 1999 0.81
130 Permanent Genetic Resources added to the Molecular Ecology Resources Database 1 February 2010-31 March 2010. Mol Ecol Resour 2010 0.80
131 Prospective, blinded comparison of helical CT and CT arterial portography in the assessment of hepatic metastasis from colorectal carcinoma. World J Surg 2006 0.80
132 Aggressive therapy is warranted for gallbladder cancer. Cancer Invest 1998 0.80
133 Comparison of phased-array and body coils for MR imaging of liver. Clin Radiol 1997 0.80
134 Malignant hepatic hilar tumors: can ultrasonography be used as an alternative to angiography with CT arterial portography for determination of resectability? J Ultrasound Med 1996 0.79
135 Novel approaches to cancer therapy using oncolytic viruses. Curr Mol Med 2003 0.79
136 Factors influencing hepatocyte trafficking during allogeneic hepatocyte transplantation: improved liver sequestration with isolated perfusion. J Surg Res 1996 0.79
137 Efficient cotransduction of tumors by multiple herpes simplex vectors: implications for tumor vaccine production. Cancer Gene Ther 2000 0.79
138 Specific organ gene transfer in vivo by regional organ perfusion with herpes viral amplicon vectors: implications for local gene therapy. Surgery 2001 0.79
139 Regional muramyl tripeptide phosphatidylethanolamine administration enhances hepatic immune function and tumor surveillance. Surgery 2000 0.79
140 A quantitative assessment of liver metabolites during jaundice using three dimensional phosphorus chemical shift imaging. Magn Reson Imaging 2000 0.79
141 Restrictive ventilatory insufficiency and lung injury induced by ischemia/reperfusion of the pancreas in rats. Transplant Proc 2008 0.78
142 Calcium depletion enhances nectin-1 expression and herpes oncolytic therapy of squamous cell carcinoma. Cancer Gene Ther 2007 0.78
143 In vitro detection of occult bone marrow metastases in patients with colorectal cancer hepatic metastases. Dis Colon Rectum 1998 0.78
144 Virally-directed fluorescent imaging (VFI) can facilitate endoscopic staging. Surg Endosc 2006 0.78
145 In vivo interleukin-2 gene therapy of established tumors with herpes simplex amplicon vectors. Cancer Immunol Immunother 1999 0.78
146 Determine whether 1 week of total parenteral nutrition (TPN) in healthy subjects alters systemic responses to a subsequent dose of endotoxin. Ann Surg 1996 0.78
147 Molecular network pathways and functional analysis of tumor signatures associated with development of resistance to viral gene therapy. Cancer Gene Ther 2011 0.77
148 Isolated single-lung perfusion with TNF-alpha in a rat sarcoma lung metastases model. Ann Thorac Surg 1994 0.77
149 A mammalian severin replaces gelsolin in transformed epithelial cells. Cancer Res 1999 0.77
150 Cytokine gene therapy for human tumors. Surg Oncol Clin N Am 1998 0.76
151 Sequence and phylogenetic analysis of the SNF4/AMPK gamma subunit gene from Drosophila melanogaster. Genome 1999 0.76
152 The effects of hepatic cryosurgery on tumor growth in the liver. J Surg Res 1998 0.76
153 Peritoneal washings are not predictive of occult peritoneal disease in patients with hilar cholangiocarcinoma. J Am Coll Surg 2001 0.76
154 Proximal bile duct tumors. Surg Oncol Clin N Am 1996 0.76
155 Consent in surgery - consent. Ann R Coll Surg Engl 2007 0.75
156 Systemic and liver cytokine activation. Implications for liver regeneration and posthepatectomy endotoxemia and sepsis. Arch Surg 1994 0.75
157 Use of radiolabelled iododeoxyuridine as adjuvant treatment for experimental tumours of the liver. Br J Surg 2003 0.75
158 The current management of hilar cholangiocarcinoma. Adv Surg 1999 0.75
159 Cytokine neutralizing strategies in experimental sepsis. Prog Clin Biol Res 1994 0.75
160 [Prognostic factors in the evaluation of colorectal liver metastases]. Chirurg 2005 0.75
161 Efficient gene transfer to human squamous cell carcinomas by the herpes simplex virus type 1 amplicon vector. Am J Surg 1998 0.75
162 Imaging of hepatobiliary neoplasms. Surg Oncol Clin N Am 1999 0.75
163 A practical guide to development of a successful robotic abdominal surgery program: The path to implementation. Rozhl Chir 2017 0.75
164 Relationship between 31P metabolites and oncolytic viral therapy sensitivity in human colorectal cancer xenografts. Br J Surg 2009 0.75
165 Nutritional and metabolic aspects of gastrointestinal cancer. Curr Opin Clin Nutr Metab Care 1999 0.75
166 Pretreatment with IFN-gamma decreases infectious complications after partial hepatectomy in the rat. J Interferon Cytokine Res 1998 0.75